A protein in the brain's immune cells may accelerate damage in Alzheimer's disease
Researchers at Lund University in Sweden have identified a key role for the protein galectin-3 in Alzheimer's disease. The study shows that galectin-3 not only influences how the brain's immune cells, known as microglia, react to the disease's characteristic amyloid plaques but also shapes the plaques themselves—and may contribute to the nerve damage that develops around them.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.